GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovate Biotechnology Co Ltd (ROCO:4130) » Definitions » Cyclically Adjusted FCF per Share

Genovate Biotechnology Co (ROCO:4130) Cyclically Adjusted FCF per Share : NT$0.19 (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Genovate Biotechnology Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Genovate Biotechnology Co's adjusted free cash flow per share for the three months ended in Mar. 2025 was NT$0.153. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$0.19 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Genovate Biotechnology Co's average Cyclically Adjusted FCF Growth Rate was 26.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -18.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Genovate Biotechnology Co was -18.30% per year. The lowest was -20.60% per year. And the median was -19.45% per year.

As of today (2025-05-29), Genovate Biotechnology Co's current stock price is NT$21.40. Genovate Biotechnology Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was NT$0.19. Genovate Biotechnology Co's Cyclically Adjusted Price-to-FCF of today is 112.63.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Genovate Biotechnology Co was 210.00. The lowest was 81.06. And the median was 113.16.


Genovate Biotechnology Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Genovate Biotechnology Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovate Biotechnology Co Cyclically Adjusted FCF per Share Chart

Genovate Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.22 0.20 0.15 0.12

Genovate Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.14 0.14 0.12 0.19

Competitive Comparison of Genovate Biotechnology Co's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Genovate Biotechnology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genovate Biotechnology Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genovate Biotechnology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Genovate Biotechnology Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Genovate Biotechnology Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genovate Biotechnology Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.153/134.9266*134.9266
=0.153

Current CPI (Mar. 2025) = 134.9266.

Genovate Biotechnology Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.102 100.684 0.137
201509 0.162 100.392 0.218
201512 -0.073 99.792 -0.099
201603 -0.191 100.470 -0.257
201606 0.080 101.688 0.106
201609 0.318 101.861 0.421
201612 0.061 101.863 0.081
201703 0.027 102.862 0.035
201706 -0.316 103.349 -0.413
201709 0.017 104.136 0.022
201712 0.210 104.011 0.272
201803 0.060 105.290 0.077
201806 0.141 106.317 0.179
201809 0.078 106.507 0.099
201812 -0.048 105.998 -0.061
201903 -0.087 107.251 -0.109
201906 0.183 108.070 0.228
201909 -0.103 108.329 -0.128
201912 0.147 108.420 0.183
202003 0.323 108.902 0.400
202006 -0.165 108.767 -0.205
202009 0.144 109.815 0.177
202012 0.237 109.897 0.291
202103 -0.159 111.754 -0.192
202106 -0.203 114.631 -0.239
202109 -0.036 115.734 -0.042
202112 0.058 117.630 0.067
202203 0.038 121.301 0.042
202206 -0.092 125.017 -0.099
202209 0.085 125.227 0.092
202212 -0.226 125.222 -0.244
202303 0.144 127.348 0.153
202306 -0.109 128.729 -0.114
202309 0.337 129.860 0.350
202312 0.087 129.419 0.091
202403 -0.144 131.776 -0.147
202406 0.264 132.554 0.269
202409 0.115 133.029 0.117
202412 -0.035 133.157 -0.035
202503 0.153 134.927 0.153

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Genovate Biotechnology Co  (ROCO:4130) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Genovate Biotechnology Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=21.40/0.19
=112.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Genovate Biotechnology Co was 210.00. The lowest was 81.06. And the median was 113.16.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Genovate Biotechnology Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Genovate Biotechnology Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Genovate Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No.1, First Industrial Road, Hsin-Chu Expanded Park, Hukou Township, Guangdong Province, Hsin-Chu county, Hsin-Chu, TWN, 303036
Genovate Biotechnology Co Ltd develops, produces, manufactures, and markets pharmaceutical preparations, drug substances, and intermediates. The company is also engaged in sales of medicines for the prevention and treatment of diseases caused by viruses and bacteria and medicines for the treatment of cardiovascular, gastrointestinal, cancer, and autoimmune diseases, etc.

Genovate Biotechnology Co Headlines

No Headlines